plasmacytoid
dendrit
cell
pdc
uniqu
dendrit
cell
subset
special
product
type
interferon
ifn
pdc
promot
antivir
immun
respons
implic
pathogenesi
autoimmun
diseas
character
type
ifn
signatur
howev
pdc
also
induc
tolerogen
immun
respons
review
recent
progress
field
pdc
biolog
focus
molecular
mechan
regul
pdc
develop
function
pathway
involv
sens
pathogen
endogen
nucleic
acid
function
pdc
mucos
site
role
infect
autoimmun
cancer
common
dc
progenitor
cdp
gener
pdc
classic
dc
cdc
cell
lineag
identifi
bone
marrow
cdp
character
lack
lineag
marker
lin
express
fmslike
tyrosin
kinas
also
known
macrophag
colonystimul
factor
receptor
mcsfr
also
known
receptor
tyrosin
kinas
kit
also
known
recent
clonogen
progenitor
downstream
cdp
promin
pdc
potenti
report
progenitor
lin
kit
intlo
express
mcsfr
express
high
level
also
known
transcript
factor
defin
pdc
lineag
deriv
cdp
condit
upregul
ie
exposur
mcsf
thrombopoietin
subsequ
step
pdc
develop
gener
pdclike
common
dc
precursor
express
phenotyp
marker
matur
pdc
siglech
low
neglig
level
mhc
class
ii
pdclike
common
dc
precursor
retain
potenti
differenti
either
pdc
cdc
depend
tissu
environ
therefor
convers
progenitor
pdc
cdc
may
happen
cdp
stage
develop
also
closer
termin
pdc
differenti
although
mani
studi
focus
pdc
differenti
within
myeloid
lineag
also
evid
pdc
origin
lymphoid
lineag
lymphoidprim
multipot
progenitor
delin
lin
kit
gener
mcsfr
progenitor
promin
pdc
potenti
describ
swiecki
colonna
plasmacytoid
dendrit
cell
pdc
origin
describ
human
lymph
node
cell
later
found
secret
high
amount
type
interferon
ifn
ie
respons
virus
therebi
correspond
enigmat
natur
ifnproduc
cell
identifi
human
peripher
blood
pdc
special
produc
type
ifn
follow
recognit
virus
self
nucleic
acid
tolllik
receptor
tlr
howev
pdc
also
secret
proinflammatori
cytokin
chemokin
includ
cxcchemokin
ligand
ccchemokin
ligand
moreov
express
mhc
class
ii
costimulatori
molecul
enabl
pdc
present
antigen
cell
thu
biolog
pdc
multifacet
figur
identif
pdc
mice
bolster
research
pdc
field
permit
explor
mechan
involv
develop
role
innat
adapt
immun
addit
contribut
innat
antivir
immun
pdc
particip
prime
immunogen
tolerogen
adapt
immun
respons
human
pdc
also
continu
extens
studi
view
understand
potenti
role
pathogenesi
autoimmun
diseas
cancer
human
immunodefici
viru
hiv
infect
review
discuss
recent
progress
made
area
mous
human
pdc
biolog
begin
discuss
phenotyp
pdc
mechan
control
develop
human
pdc
lack
express
lineageassoci
marker
select
express
ctype
lectin
also
known
igsuperfamili
receptor
human
pdc
also
express
receptor
also
known
accordingli
mediat
human
pdc
surviv
vitro
cell
adhes
molecul
express
subset
human
pdc
hi
pdc
produc
lysozym
whether
endow
capac
lyse
bacteria
unknown
marker
commonli
use
identifi
pdc
mice
bone
marrow
stromal
antigen
siglech
contrast
human
pdc
mous
pdc
express
intermedi
level
also
known
tetherin
fairli
specif
pdc
plasma
cell
steadyst
condit
induc
mani
cell
type
follow
exposur
type
type
ii
ifn
cell
suspens
primari
secondari
lymphoid
organ
siglech
express
mainli
confin
pdc
downregul
upon
activ
howev
special
macrophag
subset
spleen
lymph
node
brain
also
express
siglech
addit
studi
report
mice
confirm
siglech
mrna
transcript
progenitor
cell
mous
pdc
also
express
like
human
pdc
peripher
tissu
major
mous
pdc
express
cc
chemokin
receptor
howev
bone
marrow
marker
distinguish
pdc
subset
differ
development
stage
andor
activ
state
box
express
major
mous
pdc
peripheri
bone
marrow
marker
unequ
distribut
identifi
pdc
subset
differ
degre
matur
capac
produc
ifni
proinflammatori
cytokin
cell
pdclike
common
dc
precursor
wherea
cell
fulli
differenti
pdc
pdclike
common
dc
precursor
respond
tlr
stimul
produc
type
ifn
proinflammatori
cytokin
better
matur
pdc
pdclike
common
dc
precursor
lo
pdc
bone
marrow
divid
lo
hi
subset
lo
pdc
effici
produc
hi
pdc
give
rise
hi
pdc
activ
exposur
type
ifn
pdc
secret
type
ifn
respons
synthet
ligand
cpg
herp
simplex
viru
hsv
dna
viru
pdc
respond
poorli
stimul
influenza
viru
rna
viru
pdc
also
appear
produc
lower
level
proinflammatori
cytokin
tlr
stimul
compar
pdc
two
pdc
subset
defin
express
subset
high
type
ifn
produc
cell
stimulatori
capac
may
partial
overlap
nonplasmacytoid
high
type
ifn
produc
dc
subset
describ
bone
marrow
pdclike
common
dc
precursor
gener
studi
bone
marrow
pdc
subset
concur
newli
gener
pdc
close
precursor
may
effici
produc
type
ifn
matur
pdc
bone
marrow
peripheri
least
respons
tlr
agonist
howev
also
report
pdc
peripheri
bone
marrow
major
sourc
type
ifn
mice
infect
murin
cytomegaloviru
mcmv
like
rel
import
bone
marrow
versu
peripher
pdc
sourc
type
ifn
depend
intrins
capac
also
degre
exposur
virus
stimuli
elicit
type
ifn
respons
conclus
pdc
subset
bone
marrow
reflect
differ
stage
develop
andor
activ
differ
capac
produc
type
ifn
versu
proinflammatori
cytokin
well
impact
cell
activ
cell
effector
regulatori
function
clonogen
assay
consist
among
gate
strategi
marker
use
defin
pdc
essenti
determin
popul
contain
matur
pdc
versu
heterogen
give
rise
differ
subset
subsequ
differenti
matur
pdc
pdc
lymphoid
origin
may
distinct
pdc
myeloid
origin
report
myeloidand
lymphoidderiv
pdc
activ
lymphoidspecif
genet
program
nonproduct
rearrang
immunoglogulin
tcr
gene
express
pret
cell
receptor
alpha
ligand
crucial
pdc
develop
absenc
signal
pdc
reduc
number
lymphoid
organ
bone
marrow
mice
promot
pdc
develop
activ
signal
transduc
activ
transcript
phosphoinositid
depend
activ
mammalian
target
rapamycin
mtor
member
ragul
complex
known
inhibit
mtor
signal
condit
delet
cell
includ
cdc
pdc
caus
accumul
cell
surfac
massiv
expans
pdc
cdc
popul
older
mice
recent
shown
type
ifn
act
synergist
promot
pdc
develop
common
lymphoid
progenitor
induc
upregul
addit
signal
mcsf
also
known
may
support
gener
pdc
inde
pdc
deriv
mcsfr
cdp
mice
reduc
number
pdc
cdc
contrast
growth
factor
gmcsf
inhibit
pdc
develop
gmcsfinduc
signal
abolish
pdcrelat
gene
express
progenitor
inhibit
transcript
factor
interferon
regulatori
factor
crucial
pdc
develop
discuss
transcript
factor
essenti
commit
cdp
pdc
lineag
mice
human
figur
along
transcript
factor
heb
also
known
make
e
famili
class
basic
helixloophelix
transcript
factor
e
protein
form
homodim
heterodim
bind
conserv
e
box
sequenc
process
perturb
inhibitor
differenti
id
protein
bind
larg
fraction
pdcenrich
gene
continu
express
pdc
requir
maintain
cell
fate
delet
matur
pdc
caus
loss
pdcassoci
marker
spontan
differenti
cdclike
cell
upregul
mhc
class
ii
molecul
ultim
increas
abil
prime
cell
cdclike
cell
similar
steadyst
noncanon
dc
popul
relat
pdc
dc
requir
develop
harbor
ig
heavychain
igh
dj
rearrang
enrich
pdcspecif
gene
howev
produc
type
ifn
respons
influenza
viru
lack
surfac
express
classic
pdc
marker
like
thu
noncanon
dc
may
repres
altern
fate
pdccommit
cell
unabl
reach
maintain
high
enough
level
repressor
essenti
absent
pdc
promin
express
cdc
support
dc
develop
cdp
pdc
number
increas
mice
help
regul
balanc
e
id
protein
dc
develop
control
express
respect
stimul
express
wherea
induc
gmcsfdepend
express
figur
recent
studi
also
identifi
transcript
cofactor
eto
famili
key
factor
repress
therebi
drive
pdc
differenti
restrict
cdc
develop
figur
transcript
target
pdc
encod
protein
involv
develop
homeostasi
function
pdc
includ
transcript
factor
spib
ciita
cell
surfac
marker
siglech
nucleic
acid
sensor
figur
spib
transcript
factor
critic
differenti
hematopoiet
progenitor
pdc
control
surviv
pdc
progenitor
induct
antiapoptot
gene
pdc
number
reduc
bone
marrow
spib
mice
increas
peripheri
suggest
impair
retent
bone
marrow
furthermor
spib
pdc
exhibit
attenu
express
pdcspecif
gene
display
defect
type
ifn
product
follow
stimul
spib
also
recent
shown
novel
immunohistochem
marker
identif
human
blastic
pdc
neoplasm
necessari
express
earli
hematopoiet
progenitor
cell
wildtyp
mice
reconstitut
fetal
liver
sever
reduc
number
pdc
moreov
genomewid
analys
dna
bind
reveal
regul
transcript
therebi
induc
posit
feedback
loop
pdc
develop
essenti
pdc
dc
develop
defici
result
absenc
pdc
reduct
number
dc
well
decreas
splenic
dc
subset
competit
reconstitut
irradi
mice
wildtyp
bone
marrow
loss
pdc
cdc
monocyt
individu
mutat
impair
dna
bind
transactiv
also
report
factor
independ
nuclear
polyadenyl
rnabind
protein
mice
express
low
level
ikaro
lack
peripher
pdc
dc
subset
impair
abil
produc
type
ifn
respons
ligand
directli
regul
express
concentrationdepend
manner
necessari
pdc
cdc
develop
target
unfold
protein
respons
sensor
maintain
endoplasm
reticulum
er
homeostasi
prevent
activ
cell
death
pathway
defici
result
impair
surviv
reduc
number
pdc
cdc
treatment
pdc
proteasom
inhibitor
bortezomib
reduc
activ
form
suppress
pdc
surviv
immunostimulatori
function
target
er
homeostasi
intracellular
traffick
tlr
hypoxiainduc
factor
influenc
hematopoiesi
maintain
hsc
function
recent
shown
low
oxygen
content
upregul
suppress
pdc
develop
manner
depend
control
develop
function
pdc
cdc
manner
repress
rag
transcript
pdc
transcript
corepressor
induc
trail
express
activ
pdc
trailexpress
pdc
tumoricid
induc
apoptosi
cell
hiv
virem
patient
exposur
microrna
repres
anoth
class
regulatori
molecul
control
differ
aspect
pdc
develop
function
induc
progenitor
cultur
gmcsf
target
mrna
posttranscript
repress
overexpress
dc
develop
promot
expans
cdc
popul
expens
pdc
epigenet
chromatin
modifi
may
also
promin
role
dc
lineag
commit
develop
support
histon
deacetyl
requir
recruit
target
gene
includ
pdc
differenti
progenitor
conclus
master
transcript
factor
pdc
develop
becom
clear
compon
multiprotein
complex
includ
posit
neg
regul
studi
requir
defin
variou
compon
complex
well
genom
region
interact
complex
drive
express
molecul
defin
pdc
phenotyp
function
initi
studi
show
pdc
migrat
quit
differ
cdc
follow
develop
bone
marrow
pdc
circul
blood
reach
cell
area
lymph
node
mainli
high
endotheli
venul
hev
affer
lymphat
addit
secondari
lymphoid
organ
pdc
also
migrat
blood
peripher
tissu
pdc
migrat
involv
integrin
multipl
chemokin
receptor
figur
requir
retent
pdc
bone
marrow
stromal
nich
develop
mediat
migrat
pdc
splenic
white
swiecki
pulp
also
promot
pdc
recruit
tumor
produc
inflamm
drive
pdc
migrat
inflam
tissu
express
bimod
distribut
pdc
drive
recruit
pdc
skin
follow
inflamm
induc
topic
applic
imiquimod
express
subset
pdc
human
tonsil
facilit
migrat
inflam
epithelia
respons
pdc
recruit
thymu
small
intestin
requir
wherea
pdc
migrat
colon
integrin
recent
shown
promot
pdc
traffick
intestin
intraepitheli
compart
pdc
also
migrat
respons
engag
receptor
chemerin
adenosin
well
releas
site
tissu
damag
express
pdc
howev
role
pdc
migrat
homeostasi
well
character
sever
studi
recent
identifi
intracellular
protein
select
impact
pdc
traffick
steadyst
diseas
human
mous
pdc
express
protein
intracellular
protein
regul
actin
dynam
promot
pdc
migrat
lymph
node
inflamm
hematopoiet
cellspecif
cdm
caenorhabd
elegan
mammalian
drosophila
melanogast
myoblast
citi
protein
necessari
migrat
pdc
lymph
node
periarteriolar
lymphoid
sheath
spleen
chemokineinduc
rac
activ
sever
impair
pdc
result
reduct
motil
loss
polar
chemotaxi
recognit
virus
self
nucleic
acid
pdc
mainli
mediat
locat
endosom
compart
activ
receptor
pdc
result
secret
type
ifn
via
pathway
well
product
proinflammatori
cytokin
chemokin
via
pathway
review
whether
engag
result
product
type
ifn
proinflammatori
cytokin
depend
type
compart
tlr
encount
ligand
figur
multimer
cpga
oligonucleotid
aggreg
earli
endosom
activ
pathway
induc
type
ifn
contrast
monomer
cpgb
transfer
endolysosom
compart
activ
pathway
trigger
express
costimulatori
molecul
proinflammatori
cytokin
secret
ikappab
kinasealpha
osteopontin
mtor
key
compon
signal
pathway
essenti
signal
traffick
subcellular
compart
type
ifn
product
depend
adapt
protein
virusor
cpginduc
type
ifn
express
abolish
absenc
forward
genet
approach
identifi
encod
peptidehistidin
transport
hermanskypudlak
syndrom
protein
key
compon
requir
signal
pdc
cell
type
howev
recognit
larg
dnacontain
immun
complex
independ
requir
converg
phagocyt
autophag
pathway
process
call
microtubuleassoci
protein
chain
associ
phagocytosi
lap
involv
autophagyrel
protein
convent
autophag
preiniti
complex
recognit
live
singl
strand
rna
ssrna
virus
pdc
also
occur
distinct
subcellular
compart
requir
transport
cytosol
viral
replic
intermedi
lysosom
autophagi
sever
addit
molecul
involv
signal
identifi
pdc
scaveng
receptor
highli
express
pdc
regul
type
ifn
product
mediat
endosom
transloc
nuclear
transloc
phospholipid
scramblas
protein
regul
traffick
endosom
compart
type
ifn
product
pdc
endocyt
adapt
specif
express
mous
human
pdc
essenti
type
ifn
secret
proinflammatori
cytokin
product
viperin
ifninduc
antivir
protein
promot
signal
pdc
recruit
receptorassoci
kinas
tnf
receptorassoci
factor
lipid
bodi
induc
nuclear
transloc
addit
role
pdc
migrat
essenti
type
ifn
product
pdc
like
influenc
actin
cytoskeleton
vesicular
traffick
absenc
phosphoryl
nuclear
transloc
impair
pdc
capac
produc
proinflammatori
cytokin
maintain
signal
also
depend
bruton
tyrosin
kinas
btk
block
btk
inhibit
respons
pdc
includ
cytokin
product
express
costimulatori
molecul
addit
studi
requir
provid
integr
view
molecul
coordin
traffick
signal
properti
vesicl
pdc
although
import
pdc
detect
virus
self
nucleic
acid
recent
evid
indic
mous
pdc
also
express
permit
detect
toxoplasma
gondii
profilin
bacteri
polysaccharid
psa
respect
although
recogn
profilin
suffici
profilin
detect
pdc
trigger
product
type
ifn
activ
nk
cell
furthermor
contrast
mice
mice
highli
suscept
gondii
infect
suggest
critic
role
pdc
induct
innat
immun
respons
host
resist
psa
immunomodulatori
molecul
express
ubiquit
gut
microorgan
bacteriod
fragili
pdc
expos
psa
via
express
mhc
class
ii
induc
costimulatori
ligand
icosl
well
stimul
product
cell
requir
protect
coliti
although
tlr
establish
main
innat
receptor
involv
pdc
activ
impact
cytosol
nucleic
acid
sensor
type
ifn
proinflammatori
cytokin
product
pdc
begun
explor
cpga
oligonucleotid
select
bind
dexdhbox
helicas
associ
nuclear
transloc
type
ifn
product
pdc
contrast
cpgb
oligonucleotid
bound
result
activ
secret
proinflammatori
cytokin
pdc
addit
absenc
type
ifn
signal
virus
replic
pdc
produc
viral
nucleic
acid
detect
rigilik
helicasedepend
manner
major
cytosol
sensor
nucleic
acid
cga
sting
like
investig
pdc
near
futur
well
human
mous
pdc
express
cell
surfac
receptor
control
amplitud
type
ifn
product
pdc
activ
state
respons
ligand
mani
receptor
either
contain
intracellular
tyrosinebas
inhibitori
motif
itim
deliv
intracellular
signal
associ
adaptor
usual
dnax
activ
protein
chain
fc
receptor
intracellular
tyrosinebas
activ
motif
itam
microrna
hormon
also
impact
signal
pdc
function
express
induc
upon
engag
suppress
activ
tlrmediat
signal
pdc
starform
partner
express
pdc
signal
oppos
effect
type
ifn
product
shortli
stimul
induc
augment
type
ifn
express
inhibit
irakm
wherea
induct
occur
later
shut
type
ifn
product
target
promin
role
promot
surviv
function
pdc
target
mtor
pathway
regul
express
gene
includ
kdr
encod
growth
factor
receptor
pdc
homeostasi
capac
respond
tlr
ligand
impair
kdr
mice
indic
role
support
type
ifn
product
recent
shown
signal
pdc
enhanc
estrogen
notabl
would
provid
mechanist
basi
observ
pdc
women
produc
type
ifn
respons
hiv
pdc
men
pdc
express
mhc
class
ii
molecul
well
costimulatori
molecul
present
antigen
cell
albeit
effici
cdc
review
antigen
present
pdc
lead
cell
activ
toler
induct
depend
context
figur
pdc
receiv
activ
signal
tlr
pattern
recognit
receptor
act
immunogen
cell
pdc
either
unstimul
altern
activ
express
indoleamin
ido
icosl
program
deathligand
andor
granzym
b
promot
toler
tumor
cell
alloantigen
harmless
antigen
recent
studi
propos
pdc
captur
antigen
peripher
tissu
util
migrat
thymu
induc
delet
antigenspecif
thymocyt
thu
contribut
immun
toler
also
report
pdc
potent
induc
regulatori
reg
cell
function
inhibit
acut
graftversushost
diseas
induc
allogen
donor
cell
irradi
recipi
studi
defin
pdc
either
former
tolerogen
subset
howev
later
studi
argu
cell
subset
pdc
rather
precursor
lymphoid
tissueresid
cdc
mous
model
lung
inflamm
adopt
transfer
pdc
suppress
develop
airway
hyperreact
induc
reg
cell
howev
report
subunit
express
mous
pdc
variabl
defin
stabl
subset
corrobor
earlier
studi
found
express
fraction
pdc
steadyst
induc
major
pdc
activ
thu
role
pdc
subset
toler
remain
explor
select
examin
pdc
antigen
present
capac
antigen
specif
target
pdc
conjug
antibodi
specif
pdc
cell
surfac
molecul
recent
studi
found
target
antigen
promot
immunolog
toler
suppress
antigenspecif
cell
antibodi
respons
upon
secondari
exposur
antigen
presenc
adjuv
process
involv
preserv
treg
cell
decreas
effector
cell
antigen
target
pdc
dcir
also
present
cell
mice
shown
target
cell
epitop
deriv
myelin
oligodendrocyt
glycoprotein
mog
pdc
via
siglech
delay
onset
decreas
diseas
sever
model
moginduc
experiment
autoimmun
encephalomyel
eae
reduc
expans
polar
cell
popul
contrast
antigen
deliveri
pdc
via
combin
tlr
agonist
gener
robust
cellular
humor
immun
protect
mice
subsequ
viral
infect
tumor
growth
thu
target
antigen
pdc
either
promot
inhibit
antigenspecif
immun
respons
depend
antigen
formul
mode
stimul
deliveri
mous
model
pdc
mostli
studi
impact
antigen
present
cell
human
studi
focus
pdc
antigen
present
cell
human
pdc
recycl
endosom
peptid
continu
load
mhc
class
molecul
enabl
effici
present
viral
antigen
cell
mechan
pdc
may
contribut
adapt
respons
viral
infect
case
mous
hepat
viru
mhv
infect
pdcderiv
type
ifn
shown
critic
viral
control
mice
reduc
morbid
mortal
recent
studi
found
individu
carri
inactiv
mutat
gene
sever
defect
pdc
function
select
suscept
influenza
viru
infect
remain
determin
whether
pdc
defect
suffici
caus
suscept
influenza
gener
impact
capac
cell
respond
viru
paradox
pdc
respons
acut
viral
infect
may
alway
benefici
recent
evid
indic
excess
product
type
ifn
probabl
pdc
influenza
viru
infect
mice
result
uncontrol
inflamm
tnfrelat
apoptosisinduc
ligand
trail
mediat
apoptosi
bronchial
epithelium
thu
impact
pdc
acut
viral
infect
may
vari
consider
depend
viru
rout
infect
genet
background
role
pdc
chronic
viral
infect
even
complex
involv
pdc
activ
traffick
type
ifn
product
interact
cell
review
hiv
induc
pdc
activ
also
directli
infect
pdc
express
coreceptor
viral
entri
hiv
promot
pdc
traffick
peripher
lymph
node
reflect
reduc
number
pdc
found
blood
patient
hiv
moreov
new
evid
indic
pdc
upregul
guthom
marker
accumul
gut
mucosa
siv
hiv
infect
interestingli
pdc
elit
control
also
maintain
guthom
phenotyp
suggest
gut
traffick
pdc
independ
viral
load
pdc
may
contribut
chronic
hiv
infect
dysregul
activ
type
ifn
product
review
hivstimul
pdc
express
low
level
matur
molecul
induc
weak
cell
respons
persist
secret
type
ifn
due
hiv
traffick
earli
endosom
addit
hivstimul
pdc
produc
chemokin
express
trail
therebi
promot
recruit
apoptosi
cell
hiv
also
activ
noncanon
pathway
pdc
result
express
ido
induct
treg
cell
noncanon
signal
induct
tolerogen
pathway
pdc
stimul
high
dose
cpg
also
report
studi
human
mice
shown
deplet
pdc
prior
chronic
infect
sever
reduc
type
ifn
product
increas
viral
replic
howev
cell
death
curb
despit
elev
viral
load
suggest
pdc
suppress
replic
also
contribut
immunopathogenesi
convers
studi
simian
immunodefici
viru
siv
infect
provid
differ
view
blockad
product
pdc
diminish
immun
activ
siv
infect
suggest
sourc
type
ifn
may
contribut
immunopatholog
benefici
detriment
effect
pdc
type
ifn
chronic
viral
infect
may
also
depend
time
action
siv
infect
time
type
ifn
product
mark
effect
diseas
cours
exogen
administr
earli
augment
express
antivir
gene
prevent
system
infect
howev
sustain
treatment
induc
type
ifn
desensit
decreas
antivir
gene
express
increas
viral
load
acceler
cell
loss
mous
constitut
absenc
pdc
loss
abil
signal
chronic
lcmv
infect
appear
neg
impact
cell
prime
viral
clearanc
moreov
earli
administr
exogen
type
ifn
prevent
chronic
lcmv
infect
howev
late
type
ifn
administr
benefici
effect
fact
blockad
type
ifn
signal
chronic
lcmv
infect
improv
cell
function
diminish
viral
persist
thu
window
opportun
ie
earli
infect
type
ifn
pdc
benefici
necessari
prevent
control
chronic
viral
infect
preserv
cell
number
function
sustain
activ
pdc
also
detriment
sle
result
resist
pdc
therapeut
glucocorticoid
gc
often
administ
patient
sle
control
inflamm
bioinformat
function
analys
suggest
tlr
activ
prevent
gcinduc
pdc
apoptosi
inhibit
promot
pdc
apoptosi
target
endogen
gc
also
impact
pdc
homeostasi
surviv
regul
endogen
gc
concentr
involv
convers
inact
substrat
activ
enzym
complex
contain
dehydrogenas
type
dehydrogenas
physiolog
condit
increas
sensit
pdc
gcinduc
apoptosi
howev
follow
activ
tlr
ligand
effect
enzym
activ
overridden
genet
model
specif
address
contribut
pdc
autoimmun
lack
recent
delet
nzb
mice
mutat
lpr
mice
abolish
product
autoantibodi
diseas
manifest
studi
provid
compel
evid
pdc
respons
damag
sle
exclus
express
pdc
fact
b
cell
express
appear
necessari
express
type
ifn
pathogen
antibodi
product
mous
model
lupu
analysi
mrlfa
lpr
mice
lack
show
product
pdc
contribut
sle
pathogenesi
particularli
b
lymphopenia
nephriti
two
recent
studi
use
lupuspron
mice
specif
lack
pdc
confirm
pdc
pathogen
sle
global
haplodefici
lupuspron
mice
nearli
abolish
autoantibodi
product
glomerulonephr
wherea
transient
deplet
pdc
prior
diseas
initi
bxsb
mice
impair
expans
activ
b
cell
reduc
antinuclear
antibodi
express
type
ifninduc
gene
tissu
taken
togeth
studi
valid
pdc
therapeut
target
sle
chronic
activ
pdc
dysregul
type
ifn
product
also
appear
contribut
factor
initi
andor
promot
psoriasi
type
diabet
psoriasi
self
nucleic
acid
form
complex
antimicrobi
peptid
activ
pdc
interestingli
vitamin
analogu
calcipotriol
use
treat
psoriat
skin
lesion
trigger
tolerogen
respons
cdc
recent
shown
impair
capac
human
mous
pdc
induc
cell
prolifer
effector
cell
differenti
nonobes
diabet
nod
mous
model
activ
cell
produc
dnareact
antibodi
stimul
releas
cathelinrel
antimicrobi
peptid
cramp
neutrophil
cramp
subsequ
bind
self
dna
activ
pdc
deleteri
role
pdc
psoriasi
confirm
yet
genet
model
blockad
type
ifn
antibodymedi
deplet
pdc
appear
confer
protect
mous
model
diseas
futur
studi
necessari
address
whether
either
blockad
type
ifn
deplet
pdc
potenti
therapeut
avenu
intervent
psoriasi
human
mucos
immun
microbiom
research
rapidli
progress
pdc
resid
within
gut
gutassoci
lymphoid
tissu
also
becom
focu
increas
interest
tnbsinduc
coliti
model
psainduc
protect
highli
depend
abil
pdc
induc
gener
reg
cell
pdc
liver
mesenter
lymph
node
also
import
suppress
cell
respons
induct
oral
toler
contrast
splenic
pdc
pdc
peyer
patch
unabl
produc
type
ifn
stimul
pdc
develop
presenc
type
ifn
resembl
peyer
patch
pdc
produc
inflammatori
cytokin
stimul
cell
gener
fail
secret
tlr
engag
therefor
factor
express
mucos
site
inhibit
type
ifn
secret
pdc
block
abil
pdc
prime
cell
trigger
reg
differenti
gutassoci
pdc
also
effici
gener
mucos
b
cell
respons
normal
condit
infect
guttrop
viru
steadyst
pdc
peyer
patch
mesenter
lymph
node
induc
cellindepend
iga
product
specif
microbiota
activ
stromal
cell
produc
type
ifn
drive
pdc
express
baff
april
facilit
iga
respons
gut
viral
clearanc
protect
reinfect
rotaviru
intestin
pathogen
highli
depend
b
cell
type
ifn
product
human
mous
pdc
expos
rotaviru
appear
necessari
b
cell
activ
virusspecif
antibodi
secret
viral
clearanc
infect
microbiota
influenc
pdc
function
larg
unknown
earlier
studi
found
colon
intestin
restrict
microflora
result
lysi
pdc
activ
cytotox
lymphocyt
therefor
specif
microbi
commun
like
profound
impact
pdc
homeostasi
function
direct
indirect
mechan
although
mani
immun
function
pdc
describ
mani
question
still
remain
concern
complex
biolog
tuberculosi
human
associ
type
ifn
signatur
pdc
accumul
lymph
node
role
pdc
tuberculosi
bacteri
infect
gener
bacteri
product
activ
pdc
sensor
product
although
pdc
accumul
microenviron
tumor
reduc
cancer
chronic
lymphocyt
leukemia
cll
impact
pdc
antitumor
immun
respons
exploit
gener
effect
cell
respons
box
recruit
pdc
tumor
often
associ
poor
prognosi
tumorinfiltr
pdc
tend
tolerogen
rather
immunogen
unstimul
altern
activ
pdc
induc
reg
cell
express
ido
icosl
accumul
idoexpress
cell
tumor
drain
lymph
node
associ
wors
clinic
outcom
patient
malign
tumor
includ
breast
carcinoma
infiltr
pdc
primari
tumor
patient
invas
nonmetastat
breast
cancer
correl
shorter
surviv
time
suggest
pdc
contribut
progress
breast
cancer
breast
tumorassoci
pdc
poor
produc
type
ifn
favor
expans
reg
cell
mechan
suppress
type
ifn
product
immunogen
capac
breast
tumor
infiltr
pdc
includ
tumor
cellderiv
inhibit
type
ifn
secret
pdc
icosl
express
pdc
also
appear
correl
breast
cancer
progress
support
amplif
produc
reg
cell
recruit
pdc
ovarian
tumor
driven
associ
impair
cell
respons
poor
prognosi
compar
pdc
blood
ascit
ovarian
tumorassoci
pdc
produc
less
type
ifn
proinflammatori
cytokineschemokin
respons
tlr
stimul
induc
product
allogen
naiv
cell
suggest
play
critic
role
induct
immun
toler
progress
ovarian
cancer
human
pdc
may
also
contribut
cancer
progress
via
product
releas
proapoptot
molecul
granzym
b
suppress
cell
prolifer
activ
pdc
tlr
agonist
ligand
neg
regul
granzym
b
express
abil
pdc
suppress
cell
contrast
nk
cell
pdc
releas
poreform
protein
perforin
therefor
unabl
kill
tumor
target
cell
releas
lytic
granul
hand
pdc
promot
immunogen
antitumor
respons
appropri
stimul
inject
activ
pdc
load
tumorassoci
peptid
metastat
melanoma
patient
lead
favor
cell
respons
indic
vaccin
strategi
employ
activ
pdc
might
attract
therapeut
strategi
overcom
immun
toler
certain
type
cancer
orthotop
murin
mammari
tumor
model
intratumor
administr
ligand
result
tumorassoci
pdc
activ
potent
antitumor
effect
melanoma
mous
model
tlrstimul
pdc
mediat
tumor
kill
express
trail
granzym
b
well
activ
nk
cell
abil
pdc
produc
cytolyt
mediat
function
relev
capac
elimin
target
cell
immun
regul
extens
debat
howev
shown
fsmeimmun
vaccin
tickborn
enceph
stimul
pdc
upregul
neural
cell
adhes
molecul
also
known
trail
express
therebi
gener
subset
pdc
combin
abil
interferon
product
antigen
present
lyse
target
cell
express
also
typic
sever
neoplast
human
pdc
tumor
although
sle
gener
associ
type
ifn
signatur
recent
shown
pdc
product
type
ifn
impair
patient
carri
variant
gene
predispos
sle
observ
rais
question
whether
pdc
type
ifn
deplet
valid
strategi
sle
patient
adopt
stratif
patient
pdc
activ
recent
studi
suggest
pdc
dysfunct
autoimmun
inflammatori
diseas
may
extend
scleroderma
syndrom
wiskottaldrich
syndrom
atherosclerosi
role
pdc
inflammatori
diseas
ibd
manipul
elimin
pdc
feasibl
therapeut
strategi
diseas
whether
pdc
valid
target
viral
infect
remain
matter
debat
pdc
activ
may
benefici
earli
stage
infect
deplet
pdc
may
consid
chronic
viral
infect
hiv
type
ifn
may
exert
neg
effect
address
question
mous
model
requir
advanc
tool
deplet
pdc
vivo
develop
transgen
mice
provid
method
specif
transient
pdc
deplet
condit
target
cell
enabl
constitut
deplet
pdc
although
dc
close
relat
pdc
possibl
b
cell
subset
express
may
also
affect
import
continu
identifi
pdcspecif
gene
use
develop
pdc
lineagespecif
defici
mice
pdcspecif
cre
delet
recognit
pdc
involv
human
patholog
predict
cell
extens
evalu
diagnost
prognost
purpos
inde
interest
explor
therapeut
potenti
monoclon
antibodi
select
target
pdc
mani
diseas
scenario
discuss
less
abund
two
strand
microrna
mirna
gener
mirna
biogenesi
starform
mirna
may
import
function
mirna
regulatori
network
noncanon
pathway
nuclear
signal
induc
certain
member
tumour
necrosi
factor
receptor
superfamili
predominantli
activ
complex
contrast
canon
classic
signal
typic
involv
activ
dimer
induc
wider
rang
proinflammatori
stimuli
develop
pdc
cdp
regul
specif
cytokin
transcript
factor
signal
promot
express
master
transcript
factor
requir
pdc
develop
absenc
delet
matur
pdc
result
complet
loss
pdc
differenti
pdccommit
cell
cdclike
cell
respect
contrast
signal
block
pdc
differenti
dc
develop
induc
express
antagonist
transcript
cofactor
promot
pdc
differenti
restrict
cdc
develop
part
repress
transcript
target
encod
protein
associ
pdc
develop
homeostasi
function
spib
necessari
pdc
differenti
andor
surviv
control
pdc
homeostasi
express
chemokin
receptor
permit
egress
bone
marrow
ciita
promot
mhc
class
ii
express
siglech
marker
select
express
human
mous
pdc
involv
regul
type
ifn
product
enabl
pdc
recognit
nucleic
acid
pathogen
ie
rna
dna
virus
result
type
ifn
secret
andor
proinflammatori
cytokin
product
swiecki
pdc
express
chemokin
receptor
home
molecul
promot
recruit
steadyst
inflamm
develop
pdc
bone
marrow
bm
stromal
cell
nich
requir
express
pdc
egress
bm
blood
depend
pdc
attract
tumor
produc
shown
splenic
white
pulp
via
hematopoiet
cellspecif
cdm
famili
protein
involv
signal
also
necessari
pdc
migrat
spleen
lymph
node
ln
pdc
express
integrin
chemokin
receptor
mediat
adhes
chemotaxi
peripher
ln
splenic
white
pulp
normal
andor
inflammatori
condit
blood
pdc
express
chemerin
receptor
well
may
guid
peripher
ln
damag
tissu
intracellular
protein
regul
actin
dynam
promot
pdc
migrat
ln
inflammatori
set
drive
recruit
pdc
skin
follow
inflamm
induc
agonist
imiquimod
express
subset
human
tonsil
pdc
enabl
migrat
inflam
epithelia
produc
shown
ligand
shown
promot
traffick
peripher
pdc
thymu
requir
pdc
recruit
small
intestin
normal
inflammatori
condit
integrin
also
influenc
pdc
traffick
gut
final
pdc
express
shown
may
impact
homeostasi
pdc
sens
dna
virus
synthet
cpg
oligodeoxyribonucleotid
odn
endogen
dna
signal
requir
addit
factor
determin
whether
engag
result
type
ifn
ifni
proinflammatori
cytokin
product
factor
includ
mode
ligand
entri
intracellular
compart
encount
ligand
transport
appropri
intracellular
compart
requir
cleavag
order
recruit
dna
virus
cpg
odn
small
dna
immunecomplex
dnaic
enter
pdc
endocytosi
meet
earli
endosom
contrast
larg
dnaic
intern
phagocytosi
encount
earli
phagosom
recruit
endosom
phagosom
form
lead
ifni
product
sever
moleculespathway
involv
process
includ
osteopontin
opn
btk
viperin
mtor
pathway
altern
compart
form
endosom
phagosom
result
product
proinflammatori
cytokin
chemokin
ie
etc
process
requir
btk
cpg
odn
differ
structur
result
traffick
differ
compart
cpga
transport
endosom
strong
induc
ifni
cpgb
aggreg
endosom
potent
stimul
matur
cytokinechemokin
product
cpgc
exhibit
properti
cpga
cpgb
induc
ifni
proinflammatori
cytokin
stimul
viral
endogen
rna
may
follow
similar
pathway
